Robert T Sarisky

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 8.9

ph-index = 5

Forward Citations = 70(Granted Patents)

Location History:

Spring House, PA (US) (2013)
Yardley, PA (US) (2013 - 2014)
Lansdale, PA (US) (2010 - 2018)

Company Filing History:

9 out of 410

Janssen Biotech, Inc.

2 out of 832,680

Other

patents

Years Active: 2010-2018

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9932404 - Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist (2018-04-03),

2. 9522957 - Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists (2016-12-20),

3. 9481731 - Toll-like receptor 3 antagonists (2016-11-01),

4. 9255153 - Polynucleotides encoding Toll-Like Receptor 3 antagonists (2016-02-09),

5. 9238693 - Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies (2016-01-19),

6. 8895263 - Methods for suppressing toll-like receptor activity (2014-11-25),

7. 8540986 - Toll-like receptor 3 antagonists (2013-09-24),

8. 8460659 - Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases (2013-06-11),

9. 8409567 - Toll-like receptor 3 antagonists (2013-04-02),

10. 8277809 - CXCL13 antagonists and their use for the treatment of inflammatory diseases (2012-10-02),

11. 8153583 - Toll like receptor 3 antagonists, methods and uses (2012-04-10),

12. 7744897 - Human immunodeficiency virus gp41 mimetibody polypeptides (2010-06-29),

13. 7718778 - Antibody reactive with human toll like receptor 3 (2010-05-18),

Title: The Innovations of Robert T. Sarisky

Introduction

Robert T. Sarisky is a notable inventor based in Yardley, PA, with a significant contribution to the field of medical science. He holds a total of 13 patents, showcasing his dedication to innovation and research. His work primarily focuses on methods to combat viral infections and inflammatory conditions.

Latest Patents

Among his latest patents, Sarisky has developed methods for reducing clinical symptoms of viral infections by administering toll-like receptor 3 (TLR3) antagonists. These include TLR3 antibody antagonists, polynucleotides encoding TLR3 antibody antagonists, and methods for making and using these innovations. Additionally, he has patented a method for treating inflammatory conditions through the administration of TLR3 receptor antagonists, further emphasizing his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Sarisky has worked with prominent organizations, including Janssen Biotech, Inc. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in the medical field.

Collaborations

Some of his notable coworkers include Lani Rose San Mateo and Mark Hilary Cunningham, who have collaborated with him on various projects.

Conclusion

Robert T. Sarisky's contributions to medical science through his patents and collaborations highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in the treatment of viral infections and inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.